FR2450108B1 - Agent antitumoral contenant la souche lactobacillus casei yit 9018 - Google Patents

Agent antitumoral contenant la souche lactobacillus casei yit 9018

Info

Publication number
FR2450108B1
FR2450108B1 FR8004213A FR8004213A FR2450108B1 FR 2450108 B1 FR2450108 B1 FR 2450108B1 FR 8004213 A FR8004213 A FR 8004213A FR 8004213 A FR8004213 A FR 8004213A FR 2450108 B1 FR2450108 B1 FR 2450108B1
Authority
FR
France
Prior art keywords
strain
agent containing
antitumor agent
lactobacillus casei
casei yit
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8004213A
Other languages
English (en)
French (fr)
Other versions
FR2450108A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yakult Honsha Co Ltd
Original Assignee
Yakult Honsha Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yakult Honsha Co Ltd filed Critical Yakult Honsha Co Ltd
Publication of FR2450108A1 publication Critical patent/FR2450108A1/fr
Application granted granted Critical
Publication of FR2450108B1 publication Critical patent/FR2450108B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C12R2001/245—Lactobacillus casei

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FR8004213A 1979-02-27 1980-02-26 Agent antitumoral contenant la souche lactobacillus casei yit 9018 Expired FR2450108B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2133979A JPS55113718A (en) 1979-02-27 1979-02-27 Antitumor agent

Publications (2)

Publication Number Publication Date
FR2450108A1 FR2450108A1 (fr) 1980-09-26
FR2450108B1 true FR2450108B1 (fr) 1988-10-28

Family

ID=12052351

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8004213A Expired FR2450108B1 (fr) 1979-02-27 1980-02-26 Agent antitumoral contenant la souche lactobacillus casei yit 9018

Country Status (12)

Country Link
US (1) US4347240A (enExample)
JP (1) JPS55113718A (enExample)
BR (1) BR8001129A (enExample)
CA (1) CA1124176A (enExample)
CH (1) CH653556A5 (enExample)
DE (1) DE3007412A1 (enExample)
FR (1) FR2450108B1 (enExample)
HK (1) HK23784A (enExample)
IT (1) IT1129802B (enExample)
MY (1) MY8500010A (enExample)
NL (1) NL189999C (enExample)
SG (1) SG38183G (enExample)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3125797A1 (de) * 1981-06-30 1983-01-13 Rudolf Dr. Schuler Diaetetisches mittel
US5965414A (en) * 1985-11-04 1999-10-12 Microlife Technics, Inc. Process for producing yeast and mold inhibiting products with lactobacillus
JPH0696538B2 (ja) * 1985-12-19 1994-11-30 株式会社アドバンス 抗発癌剤
WO1991005851A1 (fr) * 1989-10-10 1991-05-02 Tartusky Gosudarstvenny Universitet Souche de bacterie de lactobacillus casei subsp casei 37 de production d'une preparation biologique bacterienne
JPH0755908B2 (ja) * 1992-11-24 1995-06-14 財団法人京都パストゥール研究所 免疫機能助長剤
WO1994026114A1 (en) * 1993-05-11 1994-11-24 Immunom Technologies, Inc. Method of stimulating and modulating the immune system of animals with microbial compositions
US7189834B2 (en) * 1993-05-11 2007-03-13 Marshall William E Oligoribonucleotides alert the immune system of animals to the imminence of microbial infection
US5840318A (en) * 1993-05-11 1998-11-24 Immunom Technologies, Inc. Methods and compositions for modulating immune systems of animals
US6180100B1 (en) * 1994-09-30 2001-01-30 Urex Biotech., Inc. Lactobacillus compositions and methods for treating urinary tract infections
AUPN907296A0 (en) * 1996-04-02 1996-04-26 Commonwealth Scientific And Industrial Research Organisation Biocontrol agents for use in treatment of opportunistic infections
WO1997049820A1 (en) 1996-06-26 1997-12-31 Kabushiki Kaisha Yakult Honsha Methods for transferring gene into chromosome
NZ337505A (en) * 1997-02-11 2001-07-27 Univ College Cork Nat Univ Ie Isolated antimicrobial agents from Lactobacillus salivarius
EP0975227B1 (en) * 1997-04-18 2005-11-09 Ganeden Biotech, Inc. Topical use of probiotic bacillus spores to prevent or control microbial infections
US6645506B1 (en) * 1997-04-18 2003-11-11 Ganeden Biotech, Inc. Topical compositions containing extracellular products of Pseudomonas lindbergii and Emu oil
ID29150A (id) * 1999-01-15 2001-08-02 Entpr Ireland Cs Penggunaan lactobacillus salivarius
PE20030283A1 (es) * 2001-07-26 2003-05-01 Alimentary Health Ltd Cepas de lactobacillus casei
EP1631308B1 (en) * 2003-05-30 2013-07-31 Amylin Pharmaceuticals, LLC Novel methods and compositions for enhanced transmucosal delivery of peptides and proteins
BRPI0413008B8 (pt) * 2003-07-30 2021-05-25 Bhph Company Ltd preparação de lactobacilos tendo uma espécie de lactobacillus casei ferm bp-10059 (ferm p-19443) e agente preventivo ou terapêutico contra infecções em humanos, animais e plantas tendo uma espécie de lactobacillus casei ferm bp-10059 (ferm p-19443)
US20050112097A1 (en) * 2003-11-26 2005-05-26 Hinton Golden S. Method for the treatment of cancer
CA2597229A1 (en) * 2005-02-11 2006-08-17 Technologie Biolactis Inc. Use of lactobacillus kefiranofaciens as a probiotic and a synbiotic
EP2075332B1 (en) * 2006-10-27 2014-04-16 Kabushiki Kaisha Yakult Honsha Cytokine production regulator gene and use thereof
CN101626773B (zh) * 2006-11-02 2013-04-17 奥力有限公司 一种生体治愈促进剂
KR20100008831A (ko) * 2008-07-17 2010-01-27 주식회사 쎌바이오텍 락토바실러스 카제이 배양물을 유효성분으로 함유하는항암용 조성물
PL2823822T3 (pl) 2009-11-11 2017-09-29 Alimentary Health Limited Szczep Bifidobakterium
CA2779418C (en) 2009-11-11 2018-03-20 Alimentary Health Limited Probiotic bifidobacterium strain
US11590179B2 (en) 2017-02-28 2023-02-28 Precisionbiotics Group Limited Bifidobacterium longum able to beneficially modulate immune response to respiratory virus infection
WO2018172537A1 (en) 2017-03-23 2018-09-27 Universiteit Antwerpen A novel probiotic lactobacillus casei strain and its uses
EP4117697A1 (en) 2020-03-13 2023-01-18 PrecisionBiotics Group Limited Bifidobacterium longum

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1514949A (fr) * 1965-06-01 1968-03-01 Texim Entpr Economique D Etat Procédé de fabrication d'une nouvelle substance à partir de culture de microorganisme du genre lactobacillus
US3632746A (en) * 1967-08-30 1972-01-04 Chugai Pharmaceutical Co Ltd Dried stable anti-tumor preparations and process for preparing the same
FR2244464A1 (en) * 1973-06-26 1975-04-18 Serozym Laboratoires Yeast, lacto- and colibacillus based compsns - used to modify intestinal flora, treat colitis and digestive disorders, etc.

Also Published As

Publication number Publication date
IT8067302A0 (it) 1980-02-27
CH653556A5 (de) 1986-01-15
FR2450108A1 (fr) 1980-09-26
JPS6234727B2 (enExample) 1987-07-28
NL8001045A (nl) 1980-08-29
NL189999B (nl) 1993-05-03
US4347240A (en) 1982-08-31
HK23784A (en) 1984-03-23
CA1124176A (en) 1982-05-25
NL189999C (nl) 1993-10-01
MY8500010A (en) 1985-12-31
BR8001129A (pt) 1980-11-04
JPS55113718A (en) 1980-09-02
DE3007412A1 (de) 1980-11-06
SG38183G (en) 1984-07-20
IT1129802B (it) 1986-06-11

Similar Documents

Publication Publication Date Title
FR2450108B1 (fr) Agent antitumoral contenant la souche lactobacillus casei yit 9018
JPS55349A (en) Novel 44*or 55 or 77* benzoylindolinee22one and its manufacture
GB1551767A (en) Implantment of living beings or the like subjects
FI822766L (fi) Framstaellning av d-mjoelksyra med hjaelp av lactobacillus bulgaricus dsm 2129
JPS54163586A (en) Novel 55fluoroo*betaa urizine or 2**deoxyybetaa urizine* derivative * production thereof and antiicancer agent containing same
JPS5511573A (en) Novel naphthoquinones*their manufacture and medical composition containing them
AU470818B2 (en) Elec i'ric switches
ES512229A0 (es) "procedimiento para la configuracion permanente del cabello".
ES512583A0 (es) "procedimiento para la mejora de la amplificacion y de la expresion de vectores hibridos".
GB2037752B (en) 2,5-inter-o-phenylene-3,4-dinor-pgf and pgi compounds
JPS55124782A (en) 22azaergolines and 22azaa8*or 9**ergolenes
JPS5543094A (en) 3*44dihydroisoquinolines*their manufacture and their medical use
JPS5620578A (en) 1*2*44triazolidinee3*55dithiones and their use
IT7828486A0 (it) Di abiti per bambole o simili eprocedimento per la fabbricazione prodotto ottenuto con il medesimo procedimento.
JPS552679A (en) 33acyll22alkylland 33acyll22aryll1*3*22 benzoxazaphosphoranes and their manufacture
GB2019870A (en) 6/7-halogenoanthraquinone compounds and the production anduse thereof
JPS5411220A (en) Thimocine alpha 1
JPS55114296A (en) Production of 7 alpha hydroxysteroids
DE3064583D1 (en) 1:1-nickel complexes and their use
ZA739100B (en) Pesticidal composition's and process
NZ181684A (en) 11-methylene-6-piperazin-1'-ylmorphanthridines
GB1553099A (en) Separation of 1,5-dinitroanthraquinone and 1,8-dinitroanthraquinone
NZ194571A (en) 9 or 11-halo-15 -hydroxy-3 17 -e-homoeburnan-14-ones
JPS5233681A (en) 44hydroxyy2hhnaphto*2*11e**1*22 thiazinee33carboxyamidee1*11dioxide and medical composite containing the compound
JPS5513297A (en) Diazepin derivative and medical compositiom